Flagship explainer
What drives Aurinia Pharmaceuticals Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| $287M | FY2025 |
| |
| Income before tax | $114M | FY2025 |
|
| Operating income | $105M | FY2025 |
|
| $283M | FY2025 |
| |
| Ending assets | $752M | FY2025 |
|
| Beginning assets | $551M | FY2024 |
|
| $581M | FY2025 |
| |
| $377M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001600620-26-000017